These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 21495200)
1. Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study. Matković B; Juretić A; Spagnoli GC; Separović V; Gamulin M; Separović R; Sarić N; Basić-Koretić M; Novosel I; Kruslin B Croat Med J; 2011 Apr; 52(2):171-7. PubMed ID: 21495200 [TBL] [Abstract][Full Text] [Related]
2. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer. Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M Tumori; 2014; 100(1):60-8. PubMed ID: 24675493 [TBL] [Abstract][Full Text] [Related]
4. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma. Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578 [TBL] [Abstract][Full Text] [Related]
6. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1. Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576 [TBL] [Abstract][Full Text] [Related]
7. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209 [TBL] [Abstract][Full Text] [Related]
8. MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours. Ishihara M; Kageyama S; Miyahara Y; Ishikawa T; Ueda S; Soga N; Naota H; Mukai K; Harada N; Ikeda H; Shiku H BMC Cancer; 2020 Jun; 20(1):606. PubMed ID: 32600281 [TBL] [Abstract][Full Text] [Related]
9. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
10. MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma. Bujas T; Marusic Z; Peric Balja M; Mijic A; Kruslin B; Tomas D Eur J Histochem; 2011 Mar; 55(1):e7. PubMed ID: 21556122 [TBL] [Abstract][Full Text] [Related]
11. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423 [TBL] [Abstract][Full Text] [Related]
12. High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer. Badovinac Črnjević T; Spagnoli G; Juretić A; Jakić-Razumović J; Podolski P; Šarić N Med Oncol; 2012 Sep; 29(3):1586-91. PubMed ID: 22116775 [TBL] [Abstract][Full Text] [Related]
13. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration. Kim SH; Lee S; Lee CH; Lee MK; Kim YD; Shin DH; Choi KU; Kim JY; Park DY; Sol MY Lung; 2009; 187(6):401-11. PubMed ID: 19795170 [TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer. Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258 [TBL] [Abstract][Full Text] [Related]
15. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing. Bao L; Dunham K; Lucas K Cancer Immunol Immunother; 2011 Sep; 60(9):1299-307. PubMed ID: 21626030 [TBL] [Abstract][Full Text] [Related]
16. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma. Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175 [TBL] [Abstract][Full Text] [Related]
17. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Jungbluth AA; Antonescu CR; Busam KJ; Iversen K; Kolb D; Coplan K; Chen YT; Stockert E; Ladanyi M; Old LJ Int J Cancer; 2001 Oct; 94(2):252-6. PubMed ID: 11668506 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059 [TBL] [Abstract][Full Text] [Related]
19. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003 [TBL] [Abstract][Full Text] [Related]
20. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma. Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]